帕那利单抗
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
CAS2329669-78-3
Storage condition -80°C for one-year storage.Avoid repeated freeze-thaw.
Security information
Product details

Bavunalimab is a bispecific human monoclonal antibody targeting CTLA-4 and LAG-3, it activates T cells in NSG mice. Bavunalimab can be used for the research of cancer.

Related literature
Related
Sorry, no related items
History
Ulocuplumab (Anti-CXCR4 / CD184)
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
Geraniol
Streptozotocin (Synonyms: Streptozocin; Streptozocin; NSC-85998; U 9889)
10-Hydroxycamptothecin; (S)-10-Hydroxycamptothecin
Anti-Human RSV Monoclonal Antibody(Motavizumab)
Simonsil
Simiarenol | Simiaren-3β-ol | β-Simiarenol
Stigmasta-4,22,25-trien-3-one
Anti-Human RSV-F Monoclonal Antibody(Palivizumab)